Fig 1: Representative immunohistochemical staining patterns of selected markers in high–grade serous carcinoma. (A,B) SARS2, (C,D) NXT2, (E,F) α–Actinin 4, (G,H) Senataxin, (I,J) Pirin, (K,L) AKAP12, (M,N) SELH, (O,P) MYPT1, (Q,R) GFAP. For each marker, the panel on the left shows lower expression (scores 0–1) and the panel on the right shows higher expression (scores 2–3). All images are shown at magnification ×400.